Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes

Over the past 20 years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern. By testing a variety of gold nanoparticles, researchers at the University of Geneva (UNIGE) and collaborators are providing first evidence of their impact upon human B lymphocytes—the immune cells responsible for antibody production. The use of these nanoparticles is expected to improve the efficacy of pharmaceutical products while limiting potential adverse effects.

* This article was originally published here